Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available
Quality of whole database:
There are several key studies available, covering bacterial point mutation testing, testing for gen mutations in mammalian cells as well as chromosome mutations in vivo. All studies are guideline conform tests according to GLP. The existing data base is therefore considered sufficient to conclude on the absence of a carcinogenic potential.

Justification for classification or non-classification

There are no indications that carcinogenicity represent an endpoint of concern. Thus, labelling & classification is not warranted.

Additional information

The following information is taken into account for the hazard / risk assessment:

Glucamine 810 is considered to not exert any in vivo carcinogenic effect by any route of exposure based on the absence of genotoxic or mutagenic properties and the absence of the induction of hyperplastic or pre-neoplastic lesions in repeated dose toxicity studies (subacute, subchronic, chronic). No indications of a carcinogenic potential exists.